Bianca Fleur Middleton (Bianca F Middleton)

Years Active: 2019-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Bianca Fleur Middleton, Margie Danchin, Mark A Jones, Amanda J Leach, Nigel Cunliffe, Carl D Kirkwood, Jonathan Carapetis, Sarah Gallagher, Lea-Ann Kirkham, Caitlyn Granland, Monica McNeal, Julie A Marsh, Claire S Waddington, Thomas L Snelling
Immunogenicity of a Third Scheduled Dose of Rotarix in Australian Indigenous Infants: A Phase IV, Double-blind, Randomized, Placebo-Controlled Clinical Trial. The Journal of infectious diseases 226 (9) (2022)
Bianca Fleur Middleton, Margie Danchin, Helen Quinn, Anna P Ralph, Nevada Pingault, Mark A Jones, Marie Estcourt, Tom Snelling
Retrospective Case-Control Study of 2017 G2P[4] Rotavirus Epidemic in Rural and Remote Australia. Pathogens (Basel, Switzerland) 9 (10) (2020)
Bianca Fleur Middleton, Mark A Jones, Claire S Waddington, Margaret Danchin, Carly McCallum, Sarah Gallagher, Amanda Jane Leach, Ross Andrews, Carl Kirkwood, Nigel Cunliffe, Jonathan Carapetis, Julie A Marsh, Tom Snelling
The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis. BMJ open 9 (11) (2019)

Bianca Fleur Middleton.css-eqlu8i{font-size:small;padding-left:4px;} (Bianca F Middleton)